Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease.

This summer’s COVID-19 wave is still lingering into the fall, as much of the country reports ongoing moderate to high disease ...

Changing seasons affect many people with Long COVID, myalgic encephalomyelitis, and other chronic illnesses, but not all in the same way. Research has a long way to go before it can explain the ...

Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Britta Shoot ...

Advocates, clinicians, and researchers must prioritize prevention and demonstrate the gravity of infection-associated chronic conditions like Long COVID by providing and wearing masks at public events ...

While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to ...

Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

This commentary article was originally published in The Gauntlet, a Substack publication by Julia Doubleday. The Sick Times has republished it with permission. Last week, The Telegraph published an ...

While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial. The novel drug ...

There were no surviving Joshua trees when we arrived at our assigned plot in the heart of California’s Mojave National Preserve. All thirteen charred Yucca brevifolia jaegeriana remained upright, ...

The U.S. Department of Defense (DOD) is funding a new clinical trials program for Long COVID with an initial grant of $8 million. Called PROBE-PASC, the program will focus on mechanistic trials that ...